The Evolution of Transcatheter Therapies for Mitral Valve Disease: From Mitral Valvuloplasty to Transcatheter Mitral Valve Replacement.
Journal
The Canadian journal of cardiology
ISSN: 1916-7075
Titre abrégé: Can J Cardiol
Pays: England
ID NLM: 8510280
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
received:
24
09
2020
revised:
13
11
2020
accepted:
18
11
2020
pubmed:
1
1
2021
medline:
13
10
2022
entrez:
31
12
2020
Statut:
ppublish
Résumé
The prevalence of mitral valve disease has evolved over the past 5 decades from primarily a disease of rheumatic origin to a disease affecting the aging population that encompasses a range of phenotypes from rheumatic mitral stenosis, degenerative mitral regurgitation, and degenerative mitral valve calcification to secondary mitral regurgitation. A reflection on the history of therapy for mitral valve disease is an expedition that follows the birth and development of structural heart intervention from the first percutaneous balloon mitral valvuloplasty to innovative technologies for transcatheter mitral valve repair and replacement. This review will lead you along this journey, pause to acknowledge the feats accomplished, and reflect on the road that lies ahead.
Identifiants
pubmed: 33383168
pii: S0828-282X(20)31187-9
doi: 10.1016/j.cjca.2020.11.018
pii:
doi:
Types de publication
Journal Article
Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
S54-S65Informations de copyright
Copyright © 2021 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.